{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T06:34:44Z","timestamp":1794378884217,"version":"4.9.0"},"reference-count":82,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100017202","name":"HM Hospitals Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017202","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","ajgponline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Geriatric Psychiatry"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.jagp.2024.11.009","type":"journal-article","created":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T16:36:39Z","timestamp":1733157399000},"page":"638-653","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Alexithymia in Parkinson's Disease: A Meta-analysis"],"prefix":"10.1016","volume":"33","author":[{"given":"Roberto","family":"Fern\u00e1ndez-Fern\u00e1ndez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Ibias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"del Toro-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo","family":"Lahera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Gasca-Salas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.jagp.2024.11.009_bib0001","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1002\/mds.27362","article-title":"Validation of the MDS clinical diagnostic criteria for Parkinson's disease","volume":"33","author":"Postuma","year":"2018","journal-title":"Mov Disord"},{"issue":"5","key":"10.1016\/j.jagp.2024.11.009_bib0002","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1136\/practneurol-2017-001650","article-title":"What a neurologist should know about depression in Parkinson's disease","volume":"17","author":"Timmer","year":"2017","journal-title":"Pract Neurol"},{"issue":"3","key":"10.1016\/j.jagp.2024.11.009_bib0003","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/s41582-023-00918-8","article-title":"Parkinson disease psychosis: from phenomenology to neurobiological mechanisms","volume":"20","author":"Pagonabarraga","year":"2024","journal-title":"Nat Rev Neurol"},{"issue":"3","key":"10.1016\/j.jagp.2024.11.009_bib0004","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0022-3999(02)00578-0","article-title":"The 20-item Toronto Alexithymia scale. III. Reliability and factorial validity in a community population","volume":"55","author":"Parker","year":"2003","journal-title":"J Psychosom Res"},{"issue":"2","key":"10.1016\/j.jagp.2024.11.009_bib0005","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1159\/000286529","article-title":"The prevalence of 'alexithymic' characteristics in psychosomatic patients","volume":"22","author":"Sifneos","year":"1973","journal-title":"Psychother Psychosom"},{"issue":"1","key":"10.1016\/j.jagp.2024.11.009_bib0006","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0022-3999(94)90005-1","article-title":"The twenty-item Toronto Alexithymia scale\u2013I. Item selection and cross-validation of the factor structure","volume":"38","author":"Bagby","year":"1994","journal-title":"J Psychosom Res"},{"issue":"1","key":"10.1016\/j.jagp.2024.11.009_bib0007","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0022-3999(98)00053-1","article-title":"Prevalence of alexithymia and its association with sociodemographic variables in the general population of Finland","volume":"46","author":"Salminen","year":"1999","journal-title":"J Psychosom Res"},{"issue":"5","key":"10.1016\/j.jagp.2024.11.009_bib0008","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.jpsychores.2006.04.013","article-title":"Age is strongly associated with alexithymia in the general population","volume":"61","author":"Mattila","year":"2006","journal-title":"J Psychosom Res"},{"key":"10.1016\/j.jagp.2024.11.009_bib0009","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.eurpsy.2018.09.004","article-title":"Investigating alexithymia in autism: a systematic review and meta-analysis","volume":"55","author":"Kinnaird","year":"2019","journal-title":"Eur Psychiatry"},{"key":"10.1016\/j.jagp.2024.11.009_bib0010","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.psychres.2019.01.033","article-title":"Alexithymia predicts poorer social and everyday functioning in schizophrenia and bipolar disorder","volume":"273","author":"Ospina","year":"2019","journal-title":"Psychiatry Res"},{"issue":"3","key":"10.1016\/j.jagp.2024.11.009_bib0011","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s00406-022-01492-8","article-title":"The percentage and clinical correlates of alexithymia in stable patients with schizophrenia","volume":"273","author":"Yi","year":"2023","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"10","key":"10.1016\/j.jagp.2024.11.009_bib0012","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1055\/a-1882-6544","article-title":"Alexithymie bei Multipler Sklerose \u2013 eine narrative \u00fcbersicht [Alexithymia in multiple sclerosis - narrative review]","volume":"91","author":"Grigorescu","year":"2023","journal-title":"Fortschr Neurol Psychiatr"},{"issue":"4","key":"10.1016\/j.jagp.2024.11.009_bib0013","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1007\/s11065-021-09484-6","article-title":"The prevalence and characteristics of alexithymia in adults following brain injury: a meta-analysis","volume":"31","author":"Fynn","year":"2021","journal-title":"Neuropsychol Rev"},{"key":"10.1016\/j.jagp.2024.11.009_bib0014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.parkreldis.2016.03.021","article-title":"Alexithymia in Parkinson's disease: a systematic review of the literature","volume":"28","author":"Assogna","year":"2016","journal-title":"Parkinsonism Relat Disord"},{"issue":"6835","key":"10.1016\/j.jagp.2024.11.009_bib0015","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/35077083","article-title":"Lesions of the human amygdala impair enhanced perception of emotionally salient events","volume":"411","author":"Anderson","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.jagp.2024.11.009_bib0016","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.neuroscience.2023.12.014","article-title":"Basolateral Amygdala functional connectivity in alexithymia: linking interoceptive sensibility and cognitive empathy","volume":"539","author":"Li","year":"2024","journal-title":"Neuroscience"},{"issue":"8","key":"10.1016\/j.jagp.2024.11.009_bib0017","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1016\/j.neubiorev.2013.07.008","article-title":"Neural correlates of alexithymia: a meta-analysis of emotion processing studies","volume":"37","author":"van der Velde","year":"2013","journal-title":"Neurosci Biobehav Rev"},{"issue":"1","key":"10.1016\/j.jagp.2024.11.009_bib0018","first-page":"21","article-title":"Alexithymia predicts cognitive deficits In patients with idiopathic Parkinson's Disease","volume":"31","author":"Gul","year":"2019","journal-title":"J Ayub Med Coll Abbottabad"},{"issue":"1","key":"10.1016\/j.jagp.2024.11.009_bib0019","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s13760-020-01581-2","article-title":"Alexithymia, depression, and cognition in patients with Parkinson's disease","volume":"123","author":"Kenangil","year":"2023","journal-title":"Acta Neurol Belg"},{"issue":"4","key":"10.1016\/j.jagp.2024.11.009_bib0020","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1159\/000322029","article-title":"Alexithymia is associated with depression in de novo Parkinson's disease","volume":"80","author":"Poletti","year":"2011","journal-title":"Psychother Psychosom"},{"issue":"8","key":"10.1016\/j.jagp.2024.11.009_bib0021","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1111\/j.1468-1331.2006.01216.x","article-title":"Alexithymia in Parkinson's disease is related to severity of depressive symptoms","volume":"13","author":"Costa","year":"2006","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.jagp.2024.11.009_bib0022","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.sleep.2020.05.039","article-title":"Severity of idiopathic rapid eye movement sleep behavior disorder correlates with depression and alexithymia","volume":"74","author":"Kim","year":"2020","journal-title":"Sleep Med"},{"issue":"1","key":"10.1016\/j.jagp.2024.11.009_bib0023","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3390\/jpm11010051","article-title":"Cognitive and neuropsychiatric profiles in idiopathic rapid eye movement sleep behavior disorder and Parkinson's Disease","volume":"11","author":"Assogna","year":"2021","journal-title":"J Pers Med"},{"issue":"2","key":"10.1016\/j.jagp.2024.11.009_bib0024","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/mds.25679","article-title":"Alexithymia-an independent risk factor for impulsive-compulsive disorders in Parkinson's disease","volume":"29","author":"Goerlich-Dobre","year":"2014","journal-title":"Mov Disord"},{"issue":"5","key":"10.1016\/j.jagp.2024.11.009_bib0025","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.nrl.2020.10.012","article-title":"Determinants and impact of alexithymia on quality of life in Parkinson's disease","volume":"38","author":"Alvarado-Bola\u00f1os","year":"2023","journal-title":"Neurologia (Engl Ed)"},{"issue":"6","key":"10.1016\/j.jagp.2024.11.009_bib0026","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3390\/brainsci10060401","article-title":"Alexithymia is associated with reduced quality of life and increased caregiver burden in Parkinson's Disease","volume":"10","author":"Klietz","year":"2020","journal-title":"Brain Sci"},{"issue":"3","key":"10.1016\/j.jagp.2024.11.009_bib0027","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1176\/appi.neuropsych.14070169","article-title":"Alexithymia in neurological disease: a review","volume":"27","author":"Ricciardi","year":"2015","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"11","key":"10.1016\/j.jagp.2024.11.009_bib0028","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.medcli.2010.01.015","article-title":"Declaraci\u00f3n PRISMA: una propuesta para mejorar la publicaci\u00f3n de revisiones sistem\u00e1ticas y metaan\u00e1lisis","volume":"135","author":"Urr\u00fatia","year":"2010","journal-title":"Med Clin (Barc)"},{"issue":"5","key":"10.1016\/j.jagp.2024.11.009_bib0029","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1111\/jgs.14779","article-title":"Multicenter validation of an MMSE-MoCA conversion table","volume":"65","author":"Bergeron","year":"2017","journal-title":"J Am Geriatr Soc"},{"issue":"14","key":"10.1016\/j.jagp.2024.11.009_bib0030","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1002\/mds.26435","article-title":"Simplified conversion method for unified Parkinson's disease rating scale motor examinations","volume":"30","author":"Hentz","year":"2015","journal-title":"Mov Disord"},{"key":"10.1016\/j.jagp.2024.11.009_bib0031","series-title":"Statistical Methods for Meta-analysis","author":"Hedges","year":"1985"},{"issue":"3","key":"10.1016\/j.jagp.2024.11.009_bib0032","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"issue":"11","key":"10.1016\/j.jagp.2024.11.009_bib0033","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"issue":"2","key":"10.1016\/j.jagp.2024.11.009_bib0034","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.0006-341X.2000.00455.x","article-title":"Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis","volume":"56","author":"Duval","year":"2000","journal-title":"Biometrics"},{"key":"10.1016\/j.jagp.2024.11.009_bib0035","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/1471-2458-13-154","article-title":"Are healthcare workers' intentions to vaccinate related to their knowledge, beliefs and attitudes? A systematic review","volume":"13","author":"Herzog","year":"2013","journal-title":"BMC Public Health"},{"issue":"4","key":"10.1016\/j.jagp.2024.11.009_bib0036","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-020512","article-title":"Health-related quality of life in Asian patients with breast cancer: a systematic review","volume":"8","author":"Ho","year":"2018","journal-title":"BMJ Open"},{"issue":"4","key":"10.1016\/j.jagp.2024.11.009_bib0037","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1155\/2013\/682393","article-title":"Alexithymia and apathy in Parkinson's disease: neurocognitive correlates","volume":"27","author":"Bogdanova","year":"2013","journal-title":"Behav Neurol"},{"issue":"4","key":"10.1016\/j.jagp.2024.11.009_bib0038","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0214957","article-title":"Voluntary and spontaneous facial mimicry toward other\u2019s emotional expression in patients with Parkinson\u2019s disease","volume":"14","author":"Kang","year":"2019","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.jagp.2024.11.009_bib0039","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0131470","article-title":"Emotion processing in Parkinson\u2019s disease: a three-level study on recognition, representation, and regulation","volume":"10","author":"Enrici","year":"2015","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.jagp.2024.11.009_bib0040","doi-asserted-by":"crossref","first-page":"E37","DOI":"10.1176\/appi.neuropsych.11110326","article-title":"Alexithymia is associated with impulsivity in newly-diagnosed, drug-na\u00efve patients with Parkinson's disease: an affective risk factor for the development of impulse-control disorders?","volume":"24","author":"Poletti","year":"2012","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.1016\/j.jagp.2024.11.009_bib0041","doi-asserted-by":"crossref","first-page":"93","DOI":"10.26657\/gulhane.00063","article-title":"The investigation of alexithymia in patients with Parkinson disease","volume":"61","author":"Sonkaya","year":"2019","journal-title":"Gulhane Med J"},{"issue":"4","key":"10.1016\/j.jagp.2024.11.009_bib0042","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1177\/02698811221144636","article-title":"Role of serotonin in modulation of decision-making in Parkinson's disease","volume":"37","author":"Nobis","year":"2023","journal-title":"J Psychopharmacol"},{"issue":"8","key":"10.1016\/j.jagp.2024.11.009_bib0043","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1097\/NMD.0000000000000853","article-title":"An initial study of alexithymia and its relationship with cognitive abilities among mild cognitive impairment, mild Alzheimer's disease, and healthy volunteers","volume":"206","author":"Smirni","year":"2018","journal-title":"J Nerv Ment Dis"},{"issue":"12","key":"10.1016\/j.jagp.2024.11.009_bib0044","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.1448","article-title":"Alexithymia and anhedonia in early Richardson\u2019s syndrome and progressive supranuclear palsy with predominant parkinsonism","volume":"9","author":"Assogna","year":"2019","journal-title":"Brain Behav"},{"key":"10.1016\/j.jagp.2024.11.009_bib0045","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.schres.2023.10.006","article-title":"Alexithymia in chronic schizophrenia and its mediating effect between cognitive deficits and negative symptoms","volume":"261","author":"Huo","year":"2023","journal-title":"Schizophr Res"},{"issue":"6","key":"10.1016\/j.jagp.2024.11.009_bib0046","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1017\/S1355617707071329","article-title":"Neuropsychological correlates of alexithymia in Parkinson's disease","volume":"13","author":"Costa","year":"2007","journal-title":"J Int Neuropsychol Soc"},{"issue":"05-06","key":"10.1016\/j.jagp.2024.11.009_bib0047","doi-asserted-by":"crossref","first-page":"199","DOI":"10.18071\/ISZ.73.0199","article-title":"Alexithymia is associated with cognitive impairment in patients with Parkinson's disease","volume":"73","author":"Sengul","year":"2020","journal-title":"Ideggyogy Sz"},{"key":"10.1016\/j.jagp.2024.11.009_bib0048","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.3389\/fpsyg.2014.01168","article-title":"Alexithymia in patients with Parkinson's disease treated with DBS of the subthalamic nucleus: a case-control study","volume":"5","author":"Castelli","year":"2014","journal-title":"Front Psychol"},{"issue":"3","key":"10.1016\/j.jagp.2024.11.009_bib0049","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/ana.410260302","article-title":"Neuropathological distinction between Parkinson's dementia and Parkinson's plus Alzheimer's disease","volume":"26","author":"de la Monte","year":"1989","journal-title":"Ann Neurol"},{"issue":"7","key":"10.1016\/j.jagp.2024.11.009_bib0050","doi-asserted-by":"crossref","first-page":"3566","DOI":"10.1002\/hbm.23610","article-title":"Limbic grey matter changes in early Parkinson's disease","volume":"38","author":"Li","year":"2017","journal-title":"Hum Brain Mapp"},{"issue":"10","key":"10.1016\/j.jagp.2024.11.009_bib0051","doi-asserted-by":"crossref","first-page":"3805","DOI":"10.1002\/hbm.22879","article-title":"Neuroanatomical profiles of alexithymia dimensions and subtypes","volume":"36","author":"Goerlich-Dobre","year":"2015","journal-title":"Hum Brain Mapp"},{"issue":"1","key":"10.1016\/j.jagp.2024.11.009_bib0052","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.neulet.2008.02.005","article-title":"Alexithymic features and automatic amygdala reactivity to facial emotion","volume":"435","author":"Kugel","year":"2008","journal-title":"Neurosci Lett"},{"issue":"1","key":"10.1016\/j.jagp.2024.11.009_bib0053","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/PSY.0b013e31820037c1","article-title":"Interaction effect of functional variants of the BDNF and DRD2\/ANKK1 gene is associated with alexithymia in healthy human subjects","volume":"73","author":"Walter","year":"2011","journal-title":"Psychosom Med"},{"issue":"2","key":"10.1016\/j.jagp.2024.11.009_bib0054","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/ene.13773","article-title":"Beneficial effects of bilateral subthalamic stimulation on alexithymia in Parkinson's disease","volume":"26","author":"Dafsari","year":"2019","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.jagp.2024.11.009_bib0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2021.105404","article-title":"Subthalamic nucleus deep brain stimulation induces sustained neurorestoration in the mesolimbic dopaminergic system in a Parkinson's disease model","volume":"156","author":"Fauser","year":"2021","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.jagp.2024.11.009_bib0056","doi-asserted-by":"crossref","first-page":"3611","DOI":"10.1093\/brain\/awq239","article-title":"Subthalamic nucleus stimulation influences expression and suppression of impulsive behaviour in Parkinson's disease","volume":"133","author":"Wylie","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.jagp.2024.11.009_bib0057","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1093\/cercor\/bhr187","article-title":"Deep brain stimulation of subthalamic nuclei affects arm response inhibition in Parkinson's patients","volume":"22","author":"Mirabella","year":"2012","journal-title":"Cereb Cortex"},{"key":"10.1016\/j.jagp.2024.11.009_bib0058","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1002\/mds.28320","article-title":"Impact of subthalamic deep brain stimulation on impulse control disorders in Parkinson's Disease: a prospective study","volume":"36","author":"Santin","year":"2021","journal-title":"Mov Disord"},{"key":"10.1016\/j.jagp.2024.11.009_bib0059","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1468-1331.2008.02509.x","article-title":"Subthalamic deep brain stimulation and impulse control in Parkinson's disease","volume":"16","author":"H\u00e4lbig","year":"2009","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.jagp.2024.11.009_bib0060","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1136\/jnnp.2006.102061","article-title":"Pathological gambling after bilateral subthalamic nucleus stimulation in Parkinson disease","volume":"78","author":"Smeding","year":"2007","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"Pt 6","key":"10.1016\/j.jagp.2024.11.009_bib0061","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1093\/brain\/119.6.2121","article-title":"Acute effects of levodopa on neuropsychological performance in stable and fluctuating Parkinson's disease patients at different levodopa plasma levels","volume":"119","author":"Kulisevsky","year":"1996","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.jagp.2024.11.009_bib0062","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/1531-8257(200007)15:4<613::AID-MDS1005>3.0.CO;2-F","article-title":"Chronic effects of dopaminergic replacement on cognitive function in Parkinson's disease: a two-year follow-up study of previously untreated patients","volume":"15","author":"Kulisevsky","year":"2000","journal-title":"Mov Disord"},{"key":"10.1016\/j.jagp.2024.11.009_bib0063","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2024.1404904","article-title":"Impulse control disorders and use of dopamine agonists in early onset Parkinson's disease","volume":"15","author":"Turcano","year":"2024","journal-title":"Front Neurol"},{"issue":"12","key":"10.1016\/j.jagp.2024.11.009_bib0064","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1093\/cercor\/11.12.1136","article-title":"Enhanced or impaired cognitive function in Parkinson's disease as a function of dopaminergic medication and task demands","volume":"11","author":"Cools","year":"2001","journal-title":"Cereb Cortex"},{"issue":"14","key":"10.1016\/j.jagp.2024.11.009_bib0065","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1002\/mds.25687","article-title":"Dopamine overdose hypothesis: evidence and clinical implications","volume":"28","author":"Vaillancourt","year":"2013","journal-title":"Mov Disord"},{"key":"10.1016\/j.jagp.2024.11.009_bib0066","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.neuropsychologia.2018.07.024","article-title":"Dopamine-related dissociation of cortical and subcortical brain activations in cognitively unimpaired Parkinson's disease patients OFF and ON medications","volume":"119","author":"Kim","year":"2018","journal-title":"Neuropsychologia"},{"key":"10.1016\/j.jagp.2024.11.009_bib0067","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1080\/14737175.2020.1806059","article-title":"'Dopamine agonist phobia' in Parkinson's disease: when does it matter? Implications for non-motor symptoms and personalized medicine","volume":"20","author":"Rota","year":"2020","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.jagp.2024.11.009_bib0068","doi-asserted-by":"crossref","first-page":"41589","DOI":"10.1038\/srep41589","article-title":"Implication of dorsostriatal D3 receptors in motivational processes: a potential target for neuropsychiatric symptoms in Parkinson's disease","volume":"7","author":"Favier","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jagp.2024.11.009_bib0069","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/pcn.13511","article-title":"Exploring the underlying mechanisms of drug-induced impulse control disorders: a pharmacovigilance-pharmacodynamic study","volume":"77","author":"Fusaroli","year":"2023","journal-title":"Psychiatry Clin Neurosci"},{"key":"10.1016\/j.jagp.2024.11.009_bib0070","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S1474-4422(04)00740-9","article-title":"Challenges in Parkinson's disease: restoration of the nigrostriatal dopamine system is not enough","volume":"3","author":"Lang","year":"2004","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jagp.2024.11.009_bib0071","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1136\/jnnp.63.5.590","article-title":"Parkinson's disease and depression: evidence for an alteration of the basal limbic system detected by transcranial sonography","volume":"63","author":"Becker","year":"1997","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jagp.2024.11.009_bib0072","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1002\/mds.20895","article-title":"Randomized study of sertraline and low-dose amitriptyline in patients with Parkinson's disease and depression: effect on quality of life","volume":"21","author":"Antonini","year":"2006","journal-title":"Mov Disord"},{"key":"10.1016\/j.jagp.2024.11.009_bib0073","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1212\/WNL.0b013e3182516244","article-title":"A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease","volume":"78","author":"Richard","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.jagp.2024.11.009_bib0074","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2022.136675","article-title":"Cognitive and affective disturbances in patients with Parkinson's disease: perspectives for classifying of motor\/neuropsychiatric subtypes","volume":"781","author":"Shkodina","year":"2022","journal-title":"Neurosci Lett"},{"issue":"3","key":"10.1016\/j.jagp.2024.11.009_bib0075","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1053\/comp.2001.23147","article-title":"Are alexithymia and depression distinct or overlapping constructs?: a study in a general population","volume":"42","author":"Hintikka","year":"2001","journal-title":"Compr Psychiatry"},{"key":"10.1016\/j.jagp.2024.11.009_bib0076","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.psychres.2015.02.006","article-title":"The association between alexithymia as assessed by the 20-item Toronto Alexithymia Scale and depression: a meta-analysis","volume":"227","author":"Li","year":"2015","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.jagp.2024.11.009_bib0077","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.psychres.2016.07.046","article-title":"Apathy, alexithymia, and depressive symptoms: points of convergence and divergence","volume":"244","author":"Ready","year":"2016","journal-title":"Psychiatry Res"},{"issue":"1","key":"10.1016\/j.jagp.2024.11.009_bib0078","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0033-3182(10)70655-1","article-title":"Prevalence and characteristics of alexithymia in Parkinson's disease","volume":"51","author":"Costa","year":"2010","journal-title":"Psychosomatics"},{"issue":"3","key":"10.1016\/j.jagp.2024.11.009_bib0079","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0022-3999(02)00601-3","article-title":"The 20-item Toronto Alexithymia scale. IV. Reliability and factorial validity in different languages and cultures","volume":"55","author":"Taylor","year":"2003","journal-title":"J Psychosom Res"},{"issue":"4","key":"10.1016\/j.jagp.2024.11.009_bib0080","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1037\/1528-3542.2.4.341","article-title":"Culture and alexithymia: mean levels, correlates, and the role of parental socialization of emotions","volume":"2","author":"Le","year":"2002","journal-title":"Emotion"},{"issue":"1","key":"10.1016\/j.jagp.2024.11.009_bib0081","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1186\/s13104-023-06660-0","article-title":"Cross-cultural differences in self-reported and behavioural emotional self-awareness between Japan and the UK","volume":"16","author":"Huggins","year":"2023","journal-title":"BMC Res Notes"},{"issue":"7","key":"10.1016\/j.jagp.2024.11.009_bib0082","doi-asserted-by":"crossref","DOI":"10.1016\/j.jstrokecerebrovasdis.2024.107712","article-title":"The prevalence and characteristics of alexithymia in stroke patients: a systematic review and meta-analysis","volume":"33","author":"Yuan","year":"2024","journal-title":"J Stroke Cerebrovasc Dis"}],"container-title":["The American Journal of Geriatric Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1064748124005396?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1064748124005396?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T16:06:49Z","timestamp":1744733209000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1064748124005396"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":82,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S1064748124005396"],"URL":"https:\/\/doi.org\/10.1016\/j.jagp.2024.11.009","relation":{},"ISSN":["1064-7481"],"issn-type":[{"value":"1064-7481","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alexithymia in Parkinson's Disease: A Meta-analysis","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Geriatric Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jagp.2024.11.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American Association for Geriatric Psychiatry. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}